European Lung Foundation
Home » SHARP Posters and Presentations at the ERS Congress – Vienna 2024
SHARP is performing well with five ongoing projects close to publication – 14 abstracts were presented at the ERS Congress this year!
“Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma”
“Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study”
“Characteristics of never-, switching, and persisting users of biologics for severe asthma – a SHARP-CRC study”
“Characteristics of severe asthma patients requiring ICU treatment across the SHARP CRC”
“Multimorbidity burden in severe asthma across the SHARP CRC”
“Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC”
“Severe Asthma Multimorbidity Clusters Across Europe; Findings From SHARP”
“European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC”
“Health-related quality of life and asthma control in patients receiving or not receiving biologic treatments for severe asthma. Data from SHARP CRC”
“Relationship between the Severe Asthma Questionnaire and the EQ-5D-5L for health-related quality of life in the SHARP CRC registry”
“Health-related quality of life (HRQoL) in depression defined by clinicians and patients in severe asthma. Data from SHARP CRC”
“The patient health-related quality of life (HRQoL) burden of severe asthma in Europe (SHARP CRC) for specific subgroups”
“The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries”
“New onset EGPA in patients on biologics for severe asthma (SA)- a multi-centre case series”